Fund Holdings — Nan Fung Group Holdings Ltd

Total Portfolio Value:
$149.67M
Total Bought:
$42.00M
Total Sold:
$1.87M
Net Transaction:
+$40.14M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
LB Pharmaceuticals Inc(LBRX)630,657630,6570$20.47M$24.20M16.17%+$3.74M
MapLight Therapeutics, Inc.(MPLT)971,2532,300,328+1,329,075$34.81M$23.44M15.66%-$11.37M
Obsidian Therapeutics Inc0918,765+918,765$0$12.61M8.43%+$12.61M
Helus Pharma Inc(HELP)987,222987,2220$6.53M$12.13M8.11%+$5.61M
Evommune, Inc.(EVMN)1,441,0321,441,0320$19.15M$11.90M7.95%-$7.25M
Nuvation Bio Inc.CL A(NUVB)01,327,224+1,327,224$0$7.43M4.97%+$7.43M
Incyte Corporation(INCY)53,74253,7420$6.09M$6.52M4.36%+$429.4K
BeOne Medicines AGADS(ONC)15,72215,7220$4.48M$5.75M3.84%+$1.27M
Rhythm Pharmaceuticals, Inc.(RYTM)49,12049,1200$5.45M$4.68M3.12%-$776.8K
Procore Technologies, Inc.(PCOR)53,29988,832+35,533$2.17M$4.59M3.07%+$2.43M
Newamsterdam Pharma Company
ORDINARY SHARES
0164,986+164,986$0$4.01M2.68%+$4.01M
Revolution Medicines, Inc.(RVMD)19,25319,2530$3.61M$3.95M2.64%+$346.2K
Kymera Therapeutics, Inc.(KYMR)30,87530,8750$3.54M$3.45M2.31%-$88.9K
Ascendis Pharma A/S(ASND)13,60013,6000$3.63M$3.10M2.07%-$528.9K
Madrigal Pharmaceuticals, Inc.(MDGL)5,6725,6720$3.05M$2.86M1.91%-$187.1K
Oculis Holding AG(OCS)300,565300,5650$4.17M$2.81M1.88%-$1.36M
argenx SEADR(ARGX)2,8002,8000$2.60M$2.68M1.79%+$87.2K
Tcgx Acquisition CorpCL A0200,000+200,000$0$2.50M1.67%+$2.50M
Celcuity Inc.(CELC)28,30028,3000$2.96M$2.25M1.50%-$710.3K
Acadia Pharmaceuticals Inc102,984102,9840$2.61M$2.08M1.39%-$530.4K
Braveheart Bio Inc081,376+81,376$0$1.64M1.10%+$1.64M
Harmony Biosciences Holdings, Inc.(HRMY)27,04927,0490$984.9K$1.06M0.71%+$77.1K
iShares Ethereum Trust ETFSHS(ETHA)50,54950,5490$601.0K$1.02M0.68%+$416.0K
iShares Bitcoin Trust ETFSHS BEN INT(IBIT)15,96815,9680$531.6K$755.9K0.51%+$224.3K
Insmed Incorporated(INSM)6,5806,5800$701.6K$751.0K0.50%+$49.5K
Recursion Pharmaceuticals, Inc.CL A(RXRX)595,287181,631-413,656$2.18M$750.1K0.50%-$1.43M
Rani Therapeutics Holdings, Inc.CL A(RANI)493,584493,5840$375.3K$390.4K0.26%+$15.1K
Entrada Therapeutics, Inc.(TRDA)49,08249,0820$361.2K$311.7K0.21%-$49.6K
Bolt Biotherapeutics Inc5,0005,0000$19.3K$18.4K0.01%-$850
Chime Financial, Inc.CL A(CHYM)21,0750-21,075$431.6K$0—-$431.6K
Page 1 of 1
Nan Fung Group Holdings Ltd — 13F Holdings — Q3 2026 | TickerTrail